Risk factors for multi-drug resistant tuberculosis in patients at tertiary care hospital, Peshawar

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 3, 2009, Pages 162-164

  Wahab, Fazli ^a,b   Ashraf, Saadia ^a   Khan, Naveed ^a   Anwar, Rukhsana ^a   Afridi, Mukhtiar Zaman ^a  

^a KHYBER TEACHING HOSPITAL   (Pakistan)

^b NONE   (Pakistan)

Author keywords

Factors; MDR TB; Multi drug resistant tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; SALINAZID; THIOACETAZONE;

ACID FAST BACTERIUM; ADULT; AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EDUCATION; FAMILY HISTORY; FEMALE; HUMAN; INCOME; INFORMED CONSENT; INTERVIEW; MALE; MEDICAL RECORD; MORBIDITY; MULTIDRUG RESISTANT TUBERCULOSIS; OBSERVATIONAL STUDY; OCCUPATION; OUTPATIENT DEPARTMENT; PAKISTAN; QUESTIONNAIRE; RISK ASSESSMENT; SEX RATIO; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PAKISTAN; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 64149085968     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Dye C, Williams BG. Criteria for the control of drug resistant tuberculosis. Proc Natl Acad Sci USA 2000; 97:8180-5.
2. World Health Organization. Global tuberculosis control; surveillance, planning, financing. WHO report, Geneva: World Health Organization, 2003.
3. Maotter T. Surveillance of tuberculosis transmission by chromosomal DNA finger printing. Infec Dis J Pak 1997; 4:3-5.
4. Mehmood A. Multi-drug resistant tuberculosis. J Pak Med Assoc 2001; 51: 204-5.
5. The WHO/IUATLD. Global project on anti-tuberculosis drug resistance surveillance: anti-tuberculosis resistance in the world. Prevalence trends: report no. 2: Geneva: World Health Organization, 2000; 20-5.
6. Hussain F. Drug resistant TB. Pak J Chest Med 2001; 7 (Suppl): 17-8.
7. Ormerold LP. Multi-drug resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull 2005; 74: 17-24.
8. Grange JM. Drug resistance and tuberculosis elimination. Bull Int Union Tuberc Lung Dis 1990; 65:57-9.
9. Rasul S, Shabbir I, Iqbal R, Masood-ul-Haq, Saulat Ullah Khan, Saeed S, et al. Trends in multi-drug resistant tuberculosis. Pak J Chest Med 2001; 7:21-8.
10. Khanj A, Usmani AQ, Abida Sultana, Hussain Z, Khan DA, Mahmood-ur-Rehman. Risk factors in development of multi-drug resistant tuberculosis in the hospitalized patients. Pak Armed Forces Med J 2005; 55:290-5.
11. Ti T, Lwin T, Mar TT, Maung W, Neo P, Htun A, et al. National antituberculosis drug resistance survey, 2002, in Myanmar. Int J Tuberc Lung Dis 2006; 10: 1111-6.
12. Clark CM, Li J, Driver CR, Munsiff SS. Risk factors for drug resistant tuberculosis among non-US-born persons in New York City. Int J Tuberc Lung Dis 2005; 9:964-9.
13. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara region, Russia. Thorax 2005; 60:130-5.
14. Faustini A, Hall AJ, Perucci CA. Risk factors for multi-drug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61:158-63.
15. Menner N, Gunther I, Orawa H, Roth A, Rambajan I, Wagner J, et al. High frequency of multi-drug resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana. Trop Med Int Health 2005; 10:1215-8.
16. Kritski AL, Rodrigues de Jesus LS, Andrade MK, Werneck-Barroso E, Vieira MA, Haffner A, et al. Retreatment tuberculosis cases. factors associated with drug resistance and adverse outcomes. Chest 1997; 111: 1162-7.
17. Almani SA, Memon NM, Qureshi AF Drug-resistant tuberculosis in Sindh. J Coll Physicians Surg Pak 2002; 12:136-9.
18. Bastian I, Colebunders R. Treatment and prevention of multidrug-resistant tuberculosis. Drugs 1999; 58:633-61.
19. Bastian I, Rigouts L, Van Deun A, Portaels F. Directory observed treatment, short course. Strategy and multidrug- resistant tubeculosis: are any modifications required? Bull World Health Organizwion 2000; 78:238-51.
20. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, et al. Using treatment failure under effective directly observed short course chemotherapy programs to identify patients with multi-drug resistant tuberculosis. Int J Tuberc Lung Dis 2000; 4: 108-14.
21. Butt T, Ahmad RN, Kazmi SY, Rafi N. Multi-drug resistant tuberculosis in Northern Pakistan. 2004; 54:469-72.